EPOXYEICOSATRIENOIC ACIDS; EPOXYGENASE METABOLITES; 12-(3-ADAMANTAN-1-YL-UREIDO)DODECANOIC ACID; THERAPEUTIC TARGET; VEGF EXPRESSION; BLOOD-PRESSURE; GENE DELETION; RENAL INJURY; IN-VIVO; HYPERTENSION
PLOS ONE, v.7, no.5
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.